North American Leads in the Cancer Biologics Global Market 2023 With the Middle East Expected to be the Fastest Growing Region
September 25, 2023 08:48 ET
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Cancer biologics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global cancer biologics market is expected...
Global Spine Biologics Market 2023-2030: Rising Demand for Minimally Invasive Procedures: A Key Driver for the Spine Biologics Market
September 22, 2023 06:33 ET
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion),...
Emerging Landscape of Targeted Protein Degradation Therapeutics, 2023 Research Report - Rapid Technology Advances Bolster a Robust Therapeutic Pipeline
September 21, 2023 04:18 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Emerging Landscape of Targeted Protein Degradation Therapeutics" report has been added to ResearchAndMarkets.com's offering. This research report...
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
September 19, 2023 16:05 ET
|
Scinai Immunotherapeutics Ltd.
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on developing, manufacturing, and commercializing...
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics
September 06, 2023 06:00 ET
|
BiondVax Pharmaceuticals Ltd.
JERUSALEM, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company, is pleased to announce today a change of its corporate name to...
MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
September 05, 2023 07:00 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Sept. 05, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia
September 05, 2023 06:00 ET
|
Zenas BioPharma
Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated...
Global Biopharmaceutical Fermentation Market 2023 - 2028: Agilent, Thermo Fisher, Lonza, Sartorius, and Eppendorf Steer the Course
September 04, 2023 08:22 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Fermentation Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
Global Biopharmaceutical Fermentation Market 2023 - 2028: Agilent, Thermo Fisher, Lonza, Sartorius, and Eppendorf Steer the Course
September 04, 2023 08:19 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Fermentation Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
Global Biotherapeutics Cell Line Development 2023-2030: Key Players, Market Trajectories, and Emerging Trends
September 04, 2023 05:53 ET
|
Research and Markets
Dublin, Sept. 04, 2023 (GLOBE NEWSWIRE) -- The "Biotherapeutics Cell Line Development: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...